UC Irvine Health
Orange, California 92868-3201
13 studies enrolling now · 36 studies all time
What they study most
Acute Myeloid Leukemia, Advanced Solid Tumors, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, B-cell Malignancy, Benign Prostatic Hyperplasia, Breast Cancer With Recurrent Brain Metastases, Cachexia, Cervical Cancer, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Phase
Studies at this site
- IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) — Recruiting now
- Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors — Recruiting now
- Pancreatic Cancer Early Detection Consortium — Recruiting now
- A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
- A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue — Recruiting now
- Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) — Recruiting now
- A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma — Recruiting now
- A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma — Recruiting now
- Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy — Recruiting now
- A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment — Recruiting now
- A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours — Recruiting now
- A Study of VET3-TGI in Patients With Solid Tumors — Recruiting now
- A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL) — Recruiting now
- AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma — Recruiting now
- Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia — Completed
- An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
- Baroreflex Activation Therapy for Heart Failure — Completed
- Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment — Completed
- Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) — Running, not enrolling
- A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises — Completed
- Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL — Stopped early
- Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated — Stopped early
- BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma — Running, not enrolling
- International Guillain-Barré Syndrome Outcome Study — Completed
- First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors — Stopped early
- Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors — Completed
- Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma — NO_LONGER_AVAILABLE
- Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) — Stopped early
- Embosphere® PROstate Post Market Study — Completed
- Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer — Stopped early
- Omega-3 Replacement With Krill Oil in Disease Management of SLE — Completed
- Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma — Completed
- Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) — Stopped early
- Protocol to Validate the Performance of the Mellitus Glycated CD59 ELISA for Gestational Diabetes Screening — Withdrawn before enrolling
- Expanded Access to ANG1005 for Individual Patients — NO_LONGER_AVAILABLE
- Medigus Ultrasonic Surgical Endostapler (MUSE) Registry — Status unconfirmed